US Walks Back Efficacy Claims About AstraZeneca’s COVID-19 Vaccine, Citing Cherry-Picked Data
Just after midnight on March 23, the United States National Institute of Allergy and Infectious Diseases announced that the independent review board overseeing AstraZeneca’s large-scale clinical trial had expressed concerns regarding the…